Only a few plasma tumor markers, such as prostate specific antigen (PSA), cancer antigen 125 (CA125), and alpha-fetoprotein (AFP), have been clinically used for early stage cancer diagnosis in the United States [14]. This evidence concerns the gene KLK3 and neoplasm.